Results for tag: "Renvela"

Renvela is a brand of phosphate binder used to treat hyperphosphatemia in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). It is used to reduce the amount of phosphate absorbed from food and beverages, helping to maintain healthy levels of phosphate in the blood. Renvela is also used to treat hyperphosphatemia in patients with liver disorders, such as cirrhosis and hepatitis. Renvela is a prescription drug and is available in tablet and powder form. The active ingredient in Renvela is sevelamer hydrochloride, a synthetic polymer that binds to phosphate in the gastrointestinal tract. It is taken orally, usually with meals, and is available in different strengths and formulations. Renvela is manufactured by Sanofi-Aventis and is available in the United States, Canada, and other countries. Other companies that produce phosphate binders for the treatment of hyperphosphatemia include Genzyme, Shire, and Fresenius Medical Care. Show Less Read more